0001225208-16-041461.txt : 20161110
0001225208-16-041461.hdr.sgml : 20161110
20161110172914
ACCESSION NUMBER: 0001225208-16-041461
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20161109
FILED AS OF DATE: 20161110
DATE AS OF CHANGE: 20161110
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Merck & Co., Inc.
CENTRAL INDEX KEY: 0000310158
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 221918501
STATE OF INCORPORATION: NJ
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2000 GALLOPING HILL ROAD
CITY: KENILWORTH
STATE: NJ
ZIP: 07033
BUSINESS PHONE: 908-740-4000
MAIL ADDRESS:
STREET 1: 2000 GALLOPING HILL ROAD
CITY: KENILWORTH
STATE: NJ
ZIP: 07033
FORMER COMPANY:
FORMER CONFORMED NAME: Merck & Co. Inc.
DATE OF NAME CHANGE: 20091103
FORMER COMPANY:
FORMER CONFORMED NAME: SCHERING PLOUGH CORP
DATE OF NAME CHANGE: 19920703
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: FRAZIER KENNETH C
CENTRAL INDEX KEY: 0001181175
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-06571
FILM NUMBER: 161989281
MAIL ADDRESS:
STREET 1: 2000 GALLOPING HILL ROAD
CITY: KENILWORTH
STATE: NJ
ZIP: 07033
4
1
doc4.xml
X0306
4
2016-11-09
0000310158
Merck & Co., Inc.
MRK
0001181175
FRAZIER KENNETH C
MERCK & CO., INC.
2000 GALLOPING HILL ROAD
KENILWORTH
NJ
07033
1
1
Chairman, President & CEO
Common Stock
2016-11-09
4
M
0
6080.0000
23.4500
A
514957.0630
D
Common Stock
2016-11-09
4
S
0
6080.0000
65.0000
D
508877.0630
D
Common Stock
2016-11-10
4
M
0
133920.0000
23.4500
A
642797.0630
D
Common Stock
2016-11-10
4
S
0
133920.0000
65.0335
D
508877.0630
D
Common Stock - 401(k) Plan
3750.4977
I
By 401(k)
Stock Option (right to buy)
23.4500
2016-11-09
4
M
0
6080.0000
0.0000
D
2010-04-24
2019-04-23
Common Stock
6080.0000
133920.0000
D
Stock Option (right to buy)
23.4500
2016-11-10
4
M
0
133920.0000
0.0000
D
2010-04-24
2019-04-23
Common Stock
133920.0000
0.0000
D
The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $65.0000 to $65.1900, inclusive. The reporting person undertakes to provide to Merck & Co., Inc., any security holder of Merck & Co., Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above in this footnote.
Holdings include shares acquired in dividend reinvestment transactions.
Includes shares acquired and dividends earned through October 7, 2016, in the Merck U.S. Savings Plan, a 401(k) plan.
The option became exercisable in equal installments on 4/24/2010, 4/24/2011 and 4/24/2012.
Katie Fedosz as Attorney-in-Fact for Kenneth C. Frazier
2016-11-10